Yale Public Health School: RSV Vaccines Would Greatly Reduce Illness If Implemented Like Flu Shots
January 03, 2024
January 03, 2024
NEW HAVEN, Connecticut, Jan. 3 (TNSres) -- Yale School of Public Health issued the following news:
By Jessica M. Scully
Respiratory syncytial virus (RSV) vaccines recently approved for people 60 and older would dramatically reduce the disease's significant burden of illness and death in the United States if they were widely adopted like annual influenza vaccines, a new study has found.
A high level of RSV vaccination would not only potentially reduce millio . . .
By Jessica M. Scully
Respiratory syncytial virus (RSV) vaccines recently approved for people 60 and older would dramatically reduce the disease's significant burden of illness and death in the United States if they were widely adopted like annual influenza vaccines, a new study has found.
A high level of RSV vaccination would not only potentially reduce millio . . .